Effective August 30, 2023, the COVID-19 Total Antibody test, which includes the qualitative detection of spike and nucleocapsid antibodies against COVID-19, will be discontinued as an orderable test at Corewell Health West Laboratories. Symptomatic patients suspected to have acute COVID-19 infection should be tested using a molecular assay.
To aid in the clinical diagnosis of multisystem inflammatory syndrome in children or adults (MIS-C or MIS-A), the COVID-19 IgG, Qualitative by CIA will be available as a send out test. This test is a qualitative detection of IgG antibodies against the nucleocapsid protein of COVID-19 that develop in response to natural infection with COVID-19. This test is performed on Monday, Wednesday, and Fridays, and reported within 1-5 days.
TEST INFORMATION
Discontinued Test: COVID-19 Total Antibody, Epic Code: LAB1230810, Interface Code: 1230810, CPT Code: 86769
Replacement Test: Reference Miscellaneous – Epic Code: LAB848 – Interface Code: 10698 – Please indicate complete test name when ordering: COVID-19 IgG, Qualitative by CIA
ADDITIONAL RESOURCES
For further guidance about how COVID-19 antibody testing should be used in the clinical setting for diagnosis of patients, please visit the CDC website and look for the Recommendations for Use of Antibody Tests.
